Completed NA INTERVENTIONAL 2-arm NCT02864537

Self-management of Anticoagulation Treatment

Comparison Between Conventional Anticoagulation Treatment and Self-management of Anticoagulation Treatment

Sponsor: University of Bergen

Conditions Artificial Heart Valve Atrial Fibrillation Venous Thromboembolism

Interventions Training

Updated 4 times since 2017 Last updated: Aug 9, 2016 Started: Jan 31, 2009 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02864537, this NA trial focuses on Artificial Heart Valve and Atrial Fibrillation and remains completed. Sponsored by University of Bergen, it has been updated 4 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Bergen

Data source: University of Bergen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.